| PDF (1MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-205861
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.20586
Zusammenfassung
We have attempted to produce the 138-kDa early protein (ep 138) of Epstein-Barr virus (EBV) in Escherichia coli. This protein was found, by immunoprecipitation, to be a clinically relevant antigen, especially for the determination of the IgA-titer in patients with nasopharyngeal carcinoma (NPC). Since the expression of the entire ep 138 coding region was unsuccessful, we synthesized only the ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik